Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.

from Section Page News - Modern Healthcare https://ift.tt/3AUembF